UBS AM’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $627K | Sell |
|
|||||
|
2024
Q4 | $1.01M | Buy |
|
|||||
|
2024
Q3 | $873K | Sell |
|
|||||
|
2024
Q2 | $820K | Buy |
|
|||||
|
2024
Q1 | $1.11M | Hold |
|
|||||
|
2023
Q4 | $2.91M | Buy |
|
|||||
|
2023
Q3 | $2.42M | Sell |
|
|||||
|
2023
Q2 | $3.37M | Hold |
|
|||||
|
2023
Q1 | $3.37M | Buy |
|
|||||
|
2022
Q4 | $2.26M | Buy |
|
|||||
|
2022
Q3 | $1.56M | Buy |
|
|||||
|
2022
Q2 | $1.07M | Sell |
|
|||||
|
2022
Q1 | $2.61M | Buy |
|
|||||
|
2021
Q4 | $4.47M | Buy |
|
|||||
|
2021
Q3 | $5.19M | Buy |
|
|||||
|
2021
Q2 | $6.28M | Buy |
|
|||||
|
2021
Q1 | $5.6M | Sell |
|
|||||
|
2020
Q4 | $5.77M | Buy |
|
|||||
|
2020
Q3 | $1.22M | Buy |
|
|||||
|
2020
Q2 | $408K | Buy |
|
|||||
|
2020
Q1 | $351K | Sell |
|
|||||
|
2019
Q4 | $1.67M | Buy |
|
|||||
|
2019
Q3 | $541K | Buy |
|
|||||
|
2019
Q2 | $578K | Buy |
|
|||||
|
2019
Q1 | $612K | Buy |
|
|||||
|
2018
Q4 | $540K | Buy |
|
|||||
|
2018
Q3 | $193K | Hold |
|
|||||
|
2018
Q2 | $126K | Hold |
|
|||||
|
2018
Q1 | $73K | Hold |
|
|||||
|
2017
Q4 | $94K | Hold |
|
|||||
|
2017
Q3 | $187K | Buy |
|
|||||
|
2017
Q2 | $65.9K | Hold |
|
|||||
|
2017
Q1 | $95.6K | Hold |
|
|||||
|
2016
Q4 | $70K | Sell |
|
|||||
|
2016
Q3 | $436K | Hold |
|
|||||
|
2016
Q2 | $342K | Buy |
|
|||||
|
2016
Q1 | $282K | Sell |
|
|||||
|
2015
Q4 | $706K | Buy |
|
|||||
|
2015
Q3 | $97K | Buy |
|
|||||
|
2015
Q2 | $107K | Hold |
|
|||||
|
2015
Q1 | $109K | Hold |
|
|||||
|
2014
Q4 | $146K | Buy |
|